Advanced Age as a Predictor of Unsuccessful Bilateral Sentinel Lymph Node Detection Using Radiocolloid Mapping in Patients With Endometrial Cancer: A Prospective Observational Study

高龄作为子宫内膜癌患者放射性胶体示踪双侧前哨淋巴结检测失败的预测因素:一项前瞻性观察研究

阅读:2

Abstract

OBJECTIVE: To identify clinical and pathological factors associated with unsuccessful bilateral sentinel lymph node (SLN) detection using the technetium-99m-labeled phytate radiocolloid method (RI method) in patients with endometrial cancer. METHODS: This prospective observational study included 223 patients with histologically confirmed presumed early-stage endometrial cancer who underwent SLN mapping between July 2018 and May 2022 at Kagoshima University Hospital. A radiocolloid tracer was injected into the cervix the day before surgery, followed by preoperative single-photon emission computed tomography combined with computed tomography imaging. The SLNs were intraoperatively localized using a gamma probe and assessed via frozen sections or one-step nucleic acid amplification. Bilateral SLN detection was defined as successful localization of at least one SLN in each hemipelvis. Multivariate logistic regression was used to identify the independent predictors of detection failure. RESULTS: The overall bilateral SLN detection rate was 83.4% (186/223). In the univariate analysis, advanced age (median 63.0 vs. 58.0 years, p = 0.0003) and myometrial invasion ≥50% (p = 0.0289) were associated with unsuccessful detection. In the multivariate analysis, age was a significant independent predictor (OR = 1.057, 95% CI: 1.017-1.099, p = 0.0037), whereas other variables, including body mass index, histological type, lymphovascular space invasion, and cervical stromal invasion, were not. CONCLUSIONS: Advanced age significantly increased the risk of unsuccessful bilateral SLN detection using the RI method for endometrial cancer. These findings emphasize the need for individualized surgical planning in older patients, including preoperative counseling and consideration of adjunctive strategies to improve detection rates, particularly in cases in which alternative tracers, such as indocyanine green, are not reimbursed.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。